Managing antipsychotic medications in schizophrenia: Comprehensive assessment and personalized care to improve clinical outcomes and reduce costs

Journal of Clinical Psychiatry

Volumn 76, Issue 9, 2015, Pages e1159-e1160

  Liperoti, Rosa ^a   Bernabei, Roberto ^a   Onder, Graziano ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

BONE DENSITY; COMORBIDITY; COST CONTROL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXTRAPYRAMIDAL SYNDROME; GAIT DISORDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIP FRACTURE; HUMAN; HYPERPROLACTINEMIA; LIFESTYLE; METABOLIC DISORDER; MORBIDITY; NOTE; ORTHOSTATIC HYPOTENSION; PERSONALIZED MEDICINE; POLYPHARMACY; PRIORITY JOURNAL; PROGNOSIS; SCHIZOPHRENIA; SCHIZOPHRENIA ASSESSMENT; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES; CHEMICALLY INDUCED; FEMALE; MALE;

ANTIPSYCHOTIC AGENTS; FEMALE; HIP FRACTURES; HUMANS; MALE; SCHIZOPHRENIA;

EID: 84943541596     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14com09571     Document Type: Note

References (20)

1. WHO. The global burden of disease 2004 update. http://www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full.pdf?ua=1. Updated 2004. Accessed February 9, 2015.
2. Simpson JC, Tsuang MT. Mortality among patients with schizophrenia. Schizophr Bull. 1996;22(3):485-499.
3. Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66(9):1122-1129.
4. Bresee LC, Majumdar SR, Patten SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. Schizophr Res. 2010;117(1):75-82.
5. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115-1121.
6. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25(2):83-88.
7. Spelman LM, Walsh PI, Sharifi N, et al. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med. 2007;24(5):481-485.
8. Roick C, Fritz-Wieacker A, Matschinger H, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2007;42(4):268-276.
9. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173(1):11-53.
10. McCreadie RG; Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry. 2003;183(6):534-539.
11. Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000;23(3):215-228.
12. Feinstein RE. Cardiovascular effects of novel antipsychotic medications. Heart Dis. 2002;4(3):184-190.
13. Wu C-S, Chang C-M, Tsai Y-T et al. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: A 10-year population-based case-control study. J Clin Psychiatry. 2015;76(9):1216-1223.
14. Liperoti R, Onder G, Lapane KL, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiatry. 2007;68(6):929-934.
15. Jalbert JJ, Eaton CB, Miller SC, et al. Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc. 2010;11(2):120-127.
16. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243-1251.
17. Halbreich U, Palter S. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull. 1996;22(3):447-454.
18. Okita K, Kanahara N, Nishimura M, et al. Second-generation antipsychotics and bone turnover in schizophrenia. Schizophr Res. 2014;157(1-3):137-141.
19. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: A systematic review and meta-analysis: I. psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30-39.
20. Zang G. Antihypertensive drugs and the risk of fall injuries: A sytematic review and metaanalysis. J Int Med Res. 2013;41(5):1408-1417.